Showing results (181-190 of 192) with videos related to
Sort By:
Pageof 20
Arthritis and Rheumatism|February 28, 2009
Prevention of cartilage degeneration in a rat model of osteoarthritis by intraarticular treatment with recombinant lubricinCarl R Flannery, Richard Zollner, Chris Corcoran, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 14, 2009
A general chemotherapy myelotoxicity score to predict febrile neutropenia in hematological malignanciesM Moreau, J Klastersky, A Schwarzbold, et al.Proceedings of the National Academy of Sciences of the United States of America|February 6, 2010
LXR modulation blocks prostaglandin E2 production and matrix degradation in cartilage and alleviates pain in a rat osteoarthritis modelNing Li, Moisés A Rivéra-Bermúdez, Mei Zhang, et al.Bone Marrow Transplantation|November 9, 2004
Stem cell transplantation from identical twins in patients with myelodysplastic syndromesN Kröger, R Brand, A van Biezen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 1998
Time to relapse has prognostic value in patients with aggressive lymphoma enrolled onto the Parma trialC Guglielmi, F Gomez, T Philip, et al.Blood|December 15, 1995
Recombinant human erythropoietin in the anemia associated with multiple myeloma or non-Hodgkin's lymphoma: dose finding and identification of predictors of responseM Cazzola, D Messinger, V Battistel, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 8, 2013
Relevance of a systematic geriatric screening and assessment in older patients with cancer: results of a prospective multicentric studyC Kenis, D Bron, Y Libert, et al.Acta Clinica Belgica|November 8, 2014
Myelofibrosis patients in Belgium: disease characteristicsT Devos, P Zachée, D Bron, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 31, 2004
Efficacy and safety of oral fludarabine phosphate in previously untreated patients with chronic lymphocytic leukemiaJ-F Rossi, A van Hoof, K de Boeck, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 22, 2017
Phase II study of copanlisib, a PI3K inhibitor, in relapsed or refractory, indolent or aggressive lymphomaM Dreyling, F Morschhauser, K Bouabdallah, et al.Pageof 20